Nutra Pharma Corp. Share Price OTC Bulletin Board
Equities
US67060U1097
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
22/03 | Nutra Pharma Corporation Appoints Michael Flax as CFO | CI |
22/03 | Nutra Pharma Corporation Announces Management Changes | CI |
Sales 2020 | 51.9K 4.33M | Sales 2021 | 97.74K 8.16M | Capitalization | 14.65M 1.22B |
---|---|---|---|---|---|
Net income 2020 | - 0 | Net income 2021 | -13M -1.09B | EV / Sales 2020 | 238 x |
Net Debt 2020 | 5.24M 438M | Net Debt 2021 | 8.3M 694M | EV / Sales 2021 | 235 x |
P/E ratio 2020 |
-10.3
x | P/E ratio 2021 |
-1.1
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 62 | 27/16/27 | |
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 07/02/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 07/02/07 |
Stewart Lonky
BRD | Director/Board Member | 75 | 05/04/05 |
Garry Pottruck
BRD | Director/Board Member | 65 | 29/09/29 |
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |